CIK 0001372514
- Non-accelerated filer
- Smaller reporting company
KIORA PHARMACEUTICALS INC
Sign in to watch- Tickers
- KPRX KPHMW
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 980443284
- Phone
- +1 858-224-9600
- Business address
- 169 SAXONY RD., SUITE 212, ENCINITAS, CA, 92024
- Former names
- EYEGATE PHARMACEUTICALS INC
Securities
- KPRX Common Stock Nasdaq
- KPHMW Common stock OTC
- 4 Shares withheld for taxes President and CEO gave up 670 shares (to pay taxes)
- 4 Shares withheld for taxes VP of Engineering gave up 122 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 122 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 712 shares (to pay taxes)
- 4 Shares withheld for taxes VP of Research & Development gave up 130 shares (to pay taxes)
- 4 Shares withheld for taxes VP of Engineering gave up 130 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 130 shares (to pay taxes)
- 4 Grant or award President and CEO acquired 20,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 10,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award VP of Engineering acquired 7,500 shares (grant or award)
- 4 Grant or award VP of Research & Development acquired 7,500 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 23,000 shares at an average $6.11 ($140,460)
- 4 Shares withheld for taxes President and CEO gave up 584 shares (to pay taxes)
- 4 Shares withheld for taxes VP of Engineering gave up 109 shares (to pay taxes)
- 4 Shares withheld for taxes VP of Research & Development gave up 109 shares (to pay taxes)
Page 10 of 21 · 406 filings